The effect of phenylephreni and ephedrine in fetal outcome in the treatment of hypotension during spinal anaesthesia for caesarean delivery by Hamid, Azhari
THE EFFECT OF PHENYLEPHRINE AND 
EPHEDRINE IN FETAL OUTCOME IN THE 
TREATMENT OF HYPOTENSION DURING 
SPINAL ANAESTHESIA FOR CAESAREAN 
DELIVERY 
by 
DR. AZHARI BIN HAMID 
Dissertation Submitted In Partial FulrJllment 
Of The Requirements for the Degree Of 
Master of Medicine 
( Anaesthesiology) 
IJHM 
UNIVERSITI SAINS MALAYSIA 
UNIVERSITI SAINS MALAYSIA 
MAY2006 
ACKNOWLEDGEMENTS 
t'*'-.;Jt ~t ~t~ 
In the name of Allah, the most gracious and the most merciful, I pray to thank Him as 
He gave me the strength, courage and health to complete my dissertation. 
I take this opportunity to wish and express my personal gratitude to all individual 
contributors. This project would not have been possible without their support, input and 
guidance. I particularly thank Associate Professor Dr Nik Abdullah Bin Nik Mohamad, 
my supervisor and Head of Department and Dr. Rhendra Hardy Bin Mohd Zaini, my 
supervisor, and also other lecturers from Department of Anaesthesiology and Intensive 
Care, Hospital Universiti Sains Malaysia for their teaching, guidance and 
encouragement throughout my course. 
My deepest thanks also to Dr Ng Siew Hian, the Head of Department and Dr Sather 
Kaur AlP Manjit Singh, Consultant Anaesthetist and other anaesthetists in Hospital 
Kuala Lumpur who gave a lot of encouragement and guidance to me to complete my 
dissertation and my master program. 
I am grateful to my colleagues for their assistance and invaluable advice during the 
preparation of this dissertation. I am especially indebted to most of the operation 
theater staffs for their help in this study. 
11 
Above all, my deepest appreciation goes to my family- my parents, my wife and my 
son for their understanding, patience and encouragement which made this dissertation 
possible. 
Dr Azhari Bin Hamid 
Final year 
Master of Medicine (Anaesthesiology) 
Universiti Sains Malaysia 
Ill 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS 
TABLE OF CONTENTS 
LIST OF TABLES 
LIST OF FIGURES 
LIST OF ABBREVIATIONS 
ABSTRAK - Bahasa Melayu 
ABSTRACT -English 
CHAPTER 1: INTRODUCTION 
I.I. OBJECTIVES 
CHAPTER 2: LITERATURE REVIEW 
2.I. SPINAL ANAESTHESIA 
2. I. I. Historical Development 
2.1.2. Spinal Anaesthesia In Obstetric 
2.I.3. BriefReview On Anatomy 
2.2. MECHANISM OF SPINAL ANAESTHESIA 
2.2.1. Local Anaesthesia 
2.2.2. Bupivacaine 
2.2.3. Opioids 
Page 
11 
lV 
lX 
X 
Xl 
Xll 
XV 
I 
2 
3 
3 
3 
4 
6 
8 
9 
10 
11 
2.3. PHYSIOLOGIC RESPONSE TO SPINAL ANAESTHESIA 
2.3.1. Cardiovascular Responses 
2.3.2. Thermoregulation 
2.3.3. Supraspinal Effects On Consciousness 
2.4. PHYSIOLOGIC CHANGES DURING PREGNANCY 
2.4.1. Hematologic Alteration 
2.4.2. Cardiovascular Changes 
2.4.3. Ventilatory Changes 
2.4.4. Metabolism 
2.4.5. Gastrointestinal Changes 
2.4.6. Altered Drug Responses 
2.4.7. Placental Transfer 
2.4.8. Apgar Score 
2.4. 9 Cord Blood Analysis 
2.5. POST SPINAL ANESTHESIA HYPOTENSION: PREVENTION AND 
TREATMENT 
2.5.1. Administration of Intravenous Fluid 
2.5.2. Positioning 
2.5.3. Vasopressor 
v 
12 
12 
14 
15 
16 
16 
17 
18 
20 
20 
22 
22 
26 
29 
31 
31 
32 
33 
2.6: PHARMACOLOGY OF THE DRUGS USED IN THE STUDY 
2.6.1. EPHEDRINE 
a. Classification 
b. Uses 
c. Presentation 
d. Pharmacodynamics I Actions 
e. Pharmacokinetics 
f Dosage and Administration 
g. Contraindications/ Precautions 
h. Drug Interactions 
i. Side Effects 
2.6.2. PHENYLEPHRINE 
a. Classification 
b. Uses 
c. Presentation 
d. Pharmacodynamics I Actions 
e. Pharmacokinetics and Metabolism 
f Dosage and Administration 
g. Contraindications I Precautions 
h. Drug Interactions 
i. Side Effects 
Vl 
35 
35 
35 
36 
37 
37 
38 
38 
38 
38 
39 
39 
39 
40 
40 
41 
41 
42 
44 
44 
45 
CHAPTER3:METHODOLOGY 
3.1. STUDY DESIGN 
3.2. INCLUSION CRITERIA 
3.3. EXCLUSION CRITERIA 
3.4. :METHODS 
3. 4. 1. Before Induction 
3.4.2. Induction 
3.5. STATISTICAL ANALYSIS 
CHAPTER4:RESULTS 
4.1. DEMOGRAPHIC DATA 
4.2. HAEMODYNAMIC DATA 
4.3. FETAL DATA 
4.4. MATERNAL DATA 
CHAPTER 5: DISCUSSION 
5.1. GENERAL 
5.2. DEMOGRAPHIC DATA 
5.3. HAEMODYNAMIC 
5.4. DISCUSSION ON FETAL DATA 
5.5. DISCUSSION ON CO:MPLICATIONS 
Vll 
46 
46 
46 
47 
47 
47 
48 
52 
54 
54 
56 
66 
68 
69 
69 
69 
70 
74 
77 
CHAPTER 6: SUMMARY AND CONCLUSION 
6.1. SillAivlAR Y 
6.2. CONCLUSION 
CHAPTER 7: LIMITATIONS 
CHAPTER 8: RECOMMENDATIONS 
REFERENCES 
APPENDICES 
Vlll 
79 
79 
82 
82 
83 
84 
92 
LIST OF TABLES 
Table Title Page 
Table 2.1 Apgar Scoring 27 
Table 4.1 Demographic profile 54 
Table 4.2 Ethnic profile 55 
Table 4.3 Haemodynamic profile 56 
Table 4.4 Haemodynamic changes 59 
Table 4.5 Atropine requirement 63 
Table 4.6 Atropine requirement according to mean baseline HR 64 
Table 4. 7 Mean fetal umbilical artery blood pH 66 
Table 4.8 Mean Fetal APGAR score 67 
Table 4.9 Maternal complication 68 
IX 
LIST OF FIGURES 
Figure Title Page 
Figure 2.1 Anatomy of vertebral column 6 
Figure 2.2 Lumbosacral portion of vertebral column showing terminal 7 
spinal cord and its coverings 
Figure 3.1 Flow chart of the study 51 
Figure 3.2 Flow chart of the anaesthetic induction 52 
Figure 4.1 Histogram (%) of patient according to frequency to drug 58 
requirement 
Figure 4.2 Mean changes in SBP at different time interval 60 
Figure 4.3 Mean changes in HR at different time interval 61 
X 
ABBREVIATIONS 
ASA 
BP 
BW 
CNS 
CSF 
DBP 
FRC 
GI 
HCL 
HR 
1M 
IV 
ICP 
LES 
MAC 
MAO 
MAP 
PaC02 
Pa02 
RPP 
SBP 
sc 
SD 
SVT 
UD 
American Society of Anaesthesiologist 
Blood Pressure 
Body Weight 
Central Nervous System 
Cerebrospinal Fluid 
Diastolic Blood Pressure 
Functional Residual Capacity 
Gastrointestinal 
Hydrochloride 
Heart Rate 
Intramuscular 
Intravenous 
Intracranial Pressure 
Lower Oesophageal Sphincter 
Minimum Alveolar Concentration 
Monoamine Oxidase 
Mean Arterial Pressure 
Partial Pressure of Carbon Dioxide in Arterial Blood 
Partial Pressure of Oxygen in Arterial Blood 
Rate Pressure Product 
Systolic Blood Pressure 
Subcutaneous 
Standard Deviation 
Supraventricular Tachycardia 
Skin Incision to Delivery Interval 
XI 
ABSTRAK 
Latar belakang: 
Halangan simpatetik yang dicirikan oleh hipotensi ialah komplikasi utama bius spinal 
pada pesakit obstetric. Rawatan dan pencegahan kesan hipotensi adalah penting kerana 
hipotensi boleh menyebabkan berkurangnya perfusi darah dalam aliran uteroplacenta, 
ini membahayakan fetus dan ibu tersebut. Pelbagai ubat dan kaedah telah digunakan 
untuk menghadapi tindakbalas ini tetapi semuanya ada masalah tersendiri. Banyak 
kajian dijalankan menggunakan ubat phenylephrine atau ephedrine untuk mencegah 
refleks hipotensi menunjukkan keputusan yang memberangsangkan disamping dapat 
mengurangkan keasidan darah fetus. Kedua-dua ubat phenylephrine dan ephedrine 
bertindak pantas dalam jangkamasa yang pendek, kami merangka satu kajian untuk 
membandingkan kebolehan ubat ini mengurangkan keasidan darah fetus dalam 
rawatan kesan hipotensif disebabkan tindak balas daripada bius spinal. 
Objektif: 
Objektif penyelidikan secara 'rawak dan dua tutupan' ini adalah untuk 
membandingkan kesan ke atas fetus yang dilahirkan di antara ibu yang mendapat 
hipotensi kesan daripada bius spinal dan dirawat dengan phenylephrine atau ephedrine 
semasa pembedahan caesarean. 
Xll 
Kaedah: 
Lima puluh em pat pesakit yang mempunyai status fisikal I atau TI ( mengikut 
klasifikasi American Society of Anaesthesiology, ASA) dan dijadual menjalani 
pembedahan elektif caesarean dibahagi secara 'rawak dan dua tutu pan' kepada dua 
kumpulan. Kedua-dua kumpulan akan menerima sama ada suntikan intravenous 
ephedrine 6 mg/ml (kumpulan kawalan) atau suntikan intravenous phenylephrine 200 
mcg/ml sebagai rawatan hipotensi kesan bius spinal. Denyut nadi (HR.), tekanan darah 
sistolik (SBP), tekanan darah diastolic (DBP) dan tekanan purata arteri (MAP) 
direkodkan sebelum rawatan tambahan diberikan dan dicatat sebagai data asal T 0. Data 
juga diambil setiap minit selepas bius spinal sehingga kelahiran fetus. Semasa 
kelahiran, sampel darah arteri umbilical diambil dan dianalisa untuk asid bes. Skor 
Apgar bayi pada I dan 5 minit selepas keahiran dicatat. Komplikasi-komplikasi lain 
yang dihadapi pesakit seperti loya, muntah dan gangguan denyut jantung juga 
diperhatikan dan direkodkan. 
Keputusan: 
Kedua-dua kumpulan ephedrine dan phenylephrine menunjukkan peningkatan tekanan 
darah sistolik, tekanan darah diastolic dan tekanan purata arteri apabila digunakan 
ketika pesakit mengalami hipotensi. Kumpulan phenylephrine menunjukkan purata 
pH umbilical arteri fetus pada nilai 7.314 berbanding dengan kumpulan yang 
menerima ephedrine (kawalan) iaitu 7.2793. Purata peningkatan pH umbilical arteri ini 
adalah signifikan dari segi statistik. Jumlah keseluruhan komplikasi juga dapat 
dikurangkan pada kumpulan yang menerima phenylephrine jika dibandingkan dengan 
kumpulan yang mendapat suntikan ephedrine (kawalan). 
Xlll 
Kesimpulan: 
Perawatan hipotensi akibat bius spinal pada pembedahan caesarean dengan 
menggunakan phenylephrine mampu meningkatkan purata pH arteri umbilical fetus 
berbanding penggunaan ephedrine. Jumlah keseluruhan komplikasi juga berjaya 
dikurangkan dalam kumpulan yang menerima rawatan dengan phenylephrine. 
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ABSTRACT 
Background: 
Sympathetic blockade manifested by hypotension is one of the most common 
complications of the regional anaesthesia in obstetric patients. Its prophylaxis and 
treatment are primarily directed towards the concern that hypotension may result in 
decreased utero placental perfusion, thus compromised fetus and maternal. Various drugs 
and methods have been used in attempts to attenuate this response but all have 
limitations. Many studies using phenylephrine or ephedrine as a prophylaxis drug to 
suppress these reflexes had shown promising results and reduce the occurrence of fetal 
acidosis. As both phenylephrine and ephedrine had rapid onset and short duration of 
action, we formulated a comparative study to evaluate the capability of this drug to 
reduce the fetal acidosis in the treatment of hypotensive response to spinal anaesthesia. 
Objectives: 
The objectives of this double-blinded, randomized study were to compare the fetal 
outcome after given phenylephrine or ephedrine as a treatment of hypotension in spinal 
anaesthesia during caesarean delivery. 
Methods: 
Fifty four patients, ASA physical status I or ll, undergoing elective lower segment 
caesarean section surgery were assigned randomly in a double blind, to receive bolus 
dose of either ephedrine (6mg/ml) or phenylephrine (200mcg/ml), given intravenously as 
XV 
a treatment of hypotension post spinal anaesthesia Heart rate (HR.), systolic blood 
pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) were 
recorded prior to spinal anaesthesia as baseline To and every minute after spinal 
anaesthesia untill delivery of the fetus. At delivery, the umbilical artery blood was 
obtained and acid base analysis performed. Apgar scores at 1 and 5 min after delivery 
was recorded. Patients were also monitored for complications such as nausea, vomiting 
and arrhythmia. 
Results: 
Both ephedrine and phenylephrine groups showed the increase of SBP, DBP and MAP 
in the treatment of hypotension. Phenylephrine group showed mean umbilical artery pH 
7.314 when compared to ephedrine (control) group 7.279. The entire increased in 
umbilical artery pH was significant statistically. Total overall complications were also 
significantly lower in phenylephrine group when compared to ephedrine (control) group. 
Conclusion: 
Phenylephrine was able to increase the mean fetal umbilical artery pH in the treatment of 
hypotension in post spinal anaesthesia patients when compared to ephedrine (control) 
group. The total complications also were lower in patients treated with phenylephrine. 
XVI 
CHAPTER 1: INTRODUCTION 
Hypotension is one of the most common complications of the regional anaesthesia 
in obstetric patients. The incidence of hypotension is high (Weeks, 2000), 
occurring as many as 40-85% despite rapid and appropriate treatment. This 
hypotension is defined as a decrease in systolic blood pressure of I 0 - 20% or to 
less than I 00 mmHg, is a result of preganglionic sympathetic nerve blockade, so 
paralysis of the sympathetic vasoconstrictor nerves to the arterioles and venous 
capacitance vessels decreased intravascular resistance and venous capacitance 
secondary to the pooling of blood in the lower extremities and abdomen. Its 
prophylaxis and treatment is primarily directed towards concern that hypotension 
may result in decreased uteroplacental perfusion, thus compromised fetus and 
maternal nausea and vomiting. 
Traditional teaching (Tsen, 2000) is that hypotension can be minimized or 
prevented by the administration of intravenous fluids, positioning of the patient 
using left uterine displacement, and by the prophylactic and therapeutic use of 
vasopressors, in particular ephedrine. The recommendation for the preferential use 
of ephedrine in the population is based on animal studies (Ralston et a/., I974, 
Hollmen et a/., 1984} which suggested a more selective constriction of systemic 
vessels with ephedrine than with phenylephrine. Other research suggested that 
alpha adrenergic agents reduce uteroplacental perfusion by increasing uterine 
vascular resistance (Tong et al., 1992). Ephedrine, however, readily crosses the 
placenta and may cause fetal tachycardia, which may misinterpret as fetal distress. 
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Many articles debating the type and amount of fluid preload, whether or not 
prophylactic vasopressor use is more efficacious than therapeutic use, and which 
vasopressor is the preferred agent in this setting. Of the three 'traditionally taught' 
measures; only the use of left uterine displacement appears to be supported and 
accepted practice utilized by all obstetric anaesthesiologists. Intravenous ephedrine, 
(Ueland et a/., 1968) given either in small bolus doses or by infusion, has been 
recommended to prevent hypotension after spinal anaesthesia during scheduled 
caesarean delivery. (Tong, 1992, Morgan, 1994 ). However, recent studies have 
challenged the efficacy of this approach. In addition, in many studies ephedrine was 
associated with lower umbilical cord pH. (Chan eta/., 1997, Shearer eta/., 1997, 
Morgan eta/., 2000, Rolbin eta/., 1982, Hughes eta/., 1985, Rout eta/., 1992). 
1.1 OBJECTIVES OF THE STUDY 
The objectives of this study were: 
1. To compare the fetal umbilical artery pH after injection of intravenous 
phenylephrine or ephedrine as a treatment of hypotension after given local 
anesthetic into subarachnoid space in caesarean delivery. 
2. To compare the fetal apgar score after injection of intravenous phenylephrine or 
ephedrine as a treatment of hypotension after given local anaesthetic into 
subarachnoid space in caesarean delivery. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 SPINAL ANAESTHESIA 
Spinal anaesthesia is produced by injection of local anaesthetic solutions into the 
lumbar subarachnoid space. Local anaesthetic solutions placed into lumbar 
cerebrospinal fluid act on superficial layers of the spinal cord, but the principal site of 
action is the preganglionic fibers as they leave the spinal cord in the anterior rami. 
2.1.1 Historical Development 
The first phase in the history of spinal anaesthesia, from 1899 to 1905, was 
characterized by the use of only cocaine for spinal anaesthesia. High frequency of 
conspicious central nervous system side effects, including tremors, hyperreflexia, 
severe headaches, and muscle spasms and pains. By the tum of the century, new and 
totally synthetic drugs were being developed. In 1905, Heinrich Braun, a German 
surgeon, reported the use of procaine for operative spinal anaesthesia. It was the first 
neurologically safe local anesthetic. Equally important, understanding of the causes of 
hypotension during spinal anaesthesia and how to manage it. (Babcock, 1913, Labat, 
1922). So, too, came refinements in the techniques of spinal anaesthesia, by making 
procaine solutions hyperbaric by adding glucose or hypobaric, initially by adding 
alcohol. The popularity of spinal anaesthesia was further advanced by the synthesis of 
tetracaine, dibucaine and these new local anaesthetics provided longer duration of 
spinal anaesthesia than procaine. Duration of spinal anaesthesia was further extended 
by the use of continuous spinal anaesthesia. By the mid-1940s spinal anaesthesia had 
reached a peak of its popularity, a popularity soon followed by almost equally 
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widespread avoidance and neglect. The era of neglect of spinal anaesthesia was 
brought about by a combination of circumstances, including the fear of neurological 
complications and scientifically unsound but widely publicized articles on 
extraordinarily high incidences of neurological sequelae. Around 1965, spinal 
anaesthesia began a recovery that has persisted and even accelerated over the last 30 
years. One studies of Dripps and Vandam demonstrating that, when properly 
performed, spinal anaesthesia is neurologically safe (Dripps et a/., 1954). Another 
factor was the introduction of new amide-type local anaesthetics. Finally, there was 
gradual acceptance of the fact that general anaesthesia, too, has risks and hazards, a 
concept to which the halothane hepatitis controversy of the 1960s and 1970s also 
contributed. 
2.1.2 Spinal Anaesthesia In Obstetric 
In 1950, Greenhill stated that spinal anaesthesia was the most dangerous anaesthetic 
to perform in pregnant women, leading to a case fatality rate in excess of that 
observed after general anaesthesia (Greenhill et al., 1950). At that time, several 
reports referred to incidence of death after spinal anaesthesia for caesarean delivery as 
high as 1:139. (Franken eta/., 1934). 
However, spinal anaesthesia was performed by personnel not trained in the technique 
and equipment for monitoring and resuscitation were scarce. In addition, many 
physicians left their patients unattended once the spinal anaesthetic had been 
performed. 
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Over the last decades, spinal anaesthesia has been the preferred anaesthetic method in 
caesarean section in many countries including Malaysia. Simplicity of the technique, 
faster onset, produces dense blocks, cost effective and devoid of significant side 
effects including local anaesthetic toxicity makes it a popular technique in comparison 
to other form of anaesthesia. Other advantage includes avoidance of intubation 
difficulty, which is higher in obstetric population due to oedema of the larynx and 
reduce oxygen reserve (Hawthorne et al., 1996). Reports from the Confidential 
Enquiries into Maternal Death from the United Kingdom (Thomas et al., 2002) as 
well as reports from the United States have demonstrated that maternal mortality is 
significantly reduced in patients receiving neuraxial as opposed to general 
anaesthesia. In the latter report, spinal anaesthesia was associated with a reduced 
incidence of systemic local anaesthetic toxicity (Hawkins et a/., 1997). 
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2.1.3 Brief Review on Anatomy of Vertebral Column 
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~===-=~~w:--=:tQ._._==:5 Lamuna 
~r=+:=-s--~ ligamentum 
Flavum 
..~---- Supraspinous 
~-- Ligament 
....._,......~- lntraspinous 
Ligament 
·~---·· Spinous 
Process 
~----~~--~-----·Transverse 
Process 
Anatomy of vertebral column 
(Adopted from Handbook of Clinical Anesthesia; fourth edition) 
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Subarachnoid~ Space 
lumbar Extra 
Dural Space 
Caudal Extra 
Oural Space· 
Sacral Hiatus 
Lumbosacral portion of vertebral column 
showing terminal spinal cord & its coverings. 
(adopted from Neural Blockade; fourth edition) 
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Spinal agents must be delivered within arachnoid's membrane (figure 2.2) in between 
the spinal vertebral column (figure 2.1). The arachnoid membrane is composed of 
overlapping layers of epithelial cells connected by tight junctions. This anatomic 
arrangement allows the arachnoid membrane to function as the principal meningeal 
barrier (90% of resistance) to materials crossing in and out of the cerebrospinal fluid 
(CSF). The arachnoid membrane serves not only as a passive container of CSF but 
also actively processes and transports agents attempting to cross the meninges. 
Recent studies demonstrated that metabolic enzymes are expressed in the arachnoid 
that can affect agents (e.g., epinephrine) and neurotransmitters important for spinal 
anaesthesia (e.g., acetylcholine). Active transport of compounds across the arachnoid 
membrane occurs in the area of the neural root cuffs. Here, unidirectional transport of 
materials from the CSF into the epidural space occurs and may contribute to 
clearance of spinal anaesthesia agents. Another potential clinical consideration of the 
lamellar structure of the arachnoid is easy separation of the arachnoid membrane 
from the dura during spinal puncture. This mechanical arrangement allows easy 
subdural deposition of spinal agents despite the free return of CSF during spinal 
injection, which may help to explain individual effects of spinal anaesthesia. 
(Michael and Philips, 2001). 
2.2 MECHANISM OF SPINAL ANAESTHESIA 
Transmission of pain from peripheral tissues to the brain is modulated in the dorsal 
hom of the spinal cord. Incoming impulse can be enhanced or attenuated by 
transmitters derived from primary afferent A-delta and C-fibers, interneuron or 
descending bulbospinal fibers (Dickenson, 1995). 
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After noxious stimulatio~ excitatory neurotransmitter such as excitatory amino acids 
(glutamate, aspartate) and peptides (substance P, calcitonin gene related peptide, 
somatostatin) are released from afferent fibers. Compensatory inhibitory 
neurotransmitter includes norepinephrine, acetylcholine and serotonin. It is the 
interplay between excitatory and inhibitory spinal neuronal systems determines the 
message delivered to higher levels of the central nervous system. 
2.2.1 Local Anaesthetics 
The site of action of local anaesthetics is the sodium channel of the neuronal cell. It 
reversibly bind to the intracellular surface of the sodium channel in its resting state 
and prevent the conformational change of the central pore which finally prevent the 
passages of sodium ions and blocking the transmission of pain. 
Unfortunately, we cannot apply local anaesthetic directly to the intracellular surface 
of the sodium channel. Whether we placed it in the epidural space or directly into the 
cerebrospinal fluid, the local anaesthetic must diffuse across at least two barriers to 
reach its site of action which are the lipid bilayers of the neuronal membrane and the 
overlying epineurium which is a non polar environment. 
By raising the pH, the equilibrium of the injected local anaesthetic can be shifted to 
favour the uncharged state which will speed the clinical onset of the block (by adding 
bicarbonate to the local anaesthetic). Neuronal morphology also has an important 
clinical implication for local anaesthetic blockade. 
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The smaller and more poorly myelinated the neuron, the more susceptible it is to 
local anaesthetic block. For example, the type C-fibers transmitting first stage 
sensation are readily blocked with a very low concentration of local anaesthetic 
whereas the A delta fibers innervating the perineum require a higher local anaesthetic 
concentration for effective blockade. 
2.2.2 Bupivacaine. 
An amide local anaesthetic. Presented as a clear colorless solution bupivacaine 
hydrochloride. The 0.25% or 0.5% solutions are available combined with 1:200,000 
adrenaline. A 0.5% (heavy) solution containing 80mglml of glucose is also available. 
Bupivacaine produce reversible neural blockade and diffuse in their uncharged base 
form through neural sheaths and the axonal to fonn a cationic species which enters the 
internal opening of the sodium ion channel, thereby decreasing sodium ion 
conductance and preventing depolarization of the cell membrane. In general, similar 
to Lignocaine but it is markedly cardiotoxic. Bind specifically to myocardial proteins. 
In toxic doses, it decreases myocardial contractility and the peripheral vascular 
resistance producing hypotension and possibly cardiovascular collapse. 
The absorption ofbupivacaine is related to the site of injection (intercostals >epidural 
> brachial plexus > subcutaneous). Addition of adrenaline does not prolong the 
duration of action. In the plasma, 95% of bupivacaine bind to the protein, with the 
volume of distribution V d of 4-103 I. It is metabolise in the liver by N-dealkylation, 
primarily to pipcolyl-oxylidine. 5% of the dose is excreted in the urine as pipcolyl-
oxylidine, 16% is excreted unchanged. 
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The clearance is 0.47 Vmin and the elimination half life is 2.7 hours. Bupivacaine may 
be administered by infiltration, intrathecally, epidurally and for major nerve blockade. 
2.2.3 Opioids 
Opioids were the first clinically used selective spinal analgesics after the discovery of 
opioid receptors in the spinal cord. Intrathecal opioids selectively decrease 
nociceptive afferent input from Ad and C fibers without affecting dorsal root axons or 
somatosensory evoked potentials. Hydrophilic opioids such as morphine provide 
excellent selective spinal analgesia because of small volume of distribution and slow 
clearance from the spinal cord. However, slow spinal cord penetration and prolonged 
duration in CSF caused by hydrophilicity also results in slow onset (30 min), 
prolonged duration of action ( 61 hours), and risk of delayed respiratory depression 
from rostral spread in CSF. Intrathecal opioids block transmission of pain-related 
information by binding at pre and postsynaptic receptors in the dorsal hom of the 
spinal cord and also at brainstem sites, which they can reach via cephalad 
cerebrospinal (CSF) spread. Opioid binding to specific mu, delta, and kappa receptors 
increases potassium conductance and hence hyperpolarizes the nerve membrane. 
Presynaptic effects include a reduced released of primary afferents neurotransmitter, 
such as substance P and glutamate (Dickenson, 1995). Post synaptically, opioids 
hyperpolarize second order projecting neurons. Furthermore, activation of presynaptic 
mu receptors on primary nerve terminals has been shown to induce release of spinal 
adenosine, which seems to be an important mediator in spinal opioid analgesia (Cahill 
et al., 1995). The intrathecal administration of opioid can deliver analgesia with fewer 
systemic side effects than equivalent dose of systemic opioids. 
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Three out of four side effects of intrathecal opioids (pruritus, nausea and vomiting, 
urinary retention and respiratory depression) (Chaney, 1995) seem to be related to 
cephalad migration of the drug in the CSF and subsequent interaction with opioid 
receptors in the brainstem (trigeminal nucleus, area postrema, ventral medulla 
respectively). The most feared side effect: - respiratory depression is thought to be 
less frequent with the lipophilic opioid, leaving little drug to ascend cephalad in CSF. 
Most side effects however are dose dependent and less common in patients 
chronically exposed to intrathecal opioid. 
2.3 PHYSIOLOGIC RESPONSE TO SPINAL ANAESTHESIA 
2.3.1 Cardiovascular Responses 
The most common serious side effects from spinal anaesthesia are hypotension and 
bradycardia (Carpenter eta/., 1992, Arndt eta/., 1998) and closed claims surveys of 
40,000-550,000 spinal anaesthetics indicate an incidence of cardiac arrest from 0.04-
1/10,000 (Auroy et a/., 1997, Aromaa et a/., 1997). Large surveillance studies 
typically observed incidences of hypotension around 33% and bradycardia around 
13% in populations. 
Risk factors for hypotension in populations include block height T5 or greater, age 40 
yr or greater, baseline systolic blood pressure less than 120 mmHg and spinal 
puncture above L3-L4. Risk factors for development of bradycardia include baseline 
heart rate less than 60 beats/min , American Society of Anaesthesiologists physical 
status I, use of P blockers, prolonged PR interval on electrocardiogram , and block 
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height TS or greater. Cardiovascular effects of spinal anaesthesia typically include a 
decrease in arterial blood pressure and central venous pressure with only minor 
decreases in heart rate, stroke volume, or cardiac output even in patients with poor left 
ventricular function (ejection fraction, 50%). Typical preservation of cardiac output 
during spinal anesthesia allows maintenance of oxygen delivery to vital organs such 
as the brain, as demonstrated by lack of change in jugular bulb oxygen saturation. The 
decrease in sympathetic activity and motor block also leads to a decrease in total body 
oxygen consumption that correlates with extent of spinal anaesthesia. Hypotension 
occurs from decreases in systemic vascular resistance and central venous pressure 
from sympathetic block with vasodilatation and redistribution of central blood volume 
to lower extremities and splanchnic beds. Various prophylactic and rescue regimens 
have been advocated for hemodynamic disturbances with emphasis on prevention of 
hypotension. Prophylactic measures include prehydration with crystalloid or colloid 
or administration of vasoactive agents. On the whole, prehydration of crystalloid 
(250- 2, 000 ml) appears to temporarily increase preload and cardiac output without 
consistently increasing arterial blood pressure or preventing hypotension. 
Pharmacokinetics of crystalloid explains its poor efficacy, as crystalloid is quickly 
redistributed from the intravascular to the extravascular space. Administration of large 
volumes of crystalloid does not appear to confer additional benefit over small 
volumes (250 ml) and may be detrimental to patients with limited cardiopulmonary 
reserve. Prehydration with colloid ( 500 ml) appears to be more effective than 
crystalloid at maintaining arterial blood pressure and perhaps decreasing incidence of 
hypotension depending on definition and population. The greater effectiveness of 
colloid is a result of greater effect for increasing central venous pressure and cardiac 
output caused by slower redistribution out of the intravascular space. In contrast to 
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prophylaxis, treatment of hypotension during spinal anaesthesia will be effective with 
crystalloid or colloid because of changes in kinetics induced by spinal anaesthesia and 
intravascular hypovolemia. Both clinical scenarios alter kinetics of crystalloid and 
colloid to allow retention within the intravascular space. Prophylactic administration 
of pharmacologic agents may be more effective than prehydration for prevention of 
hypotension. a-Adrenergic agonists (e.g., metaraminol, phenylephrine) reliably 
increase arterial blood pressure by increasing systemic vascular resistance; however, 
heart rate and cardiac output may decrease because of increased afterload. Mixed a-
and f3-adrenergic agents (e.g., ephedrine, epinephrine) are also effective for increasing 
arterial blood pressure and preventing hypotension but act by primarily increasing 
heart rate and cardiac output with a smaller increase in systemic vascular resistance. 
/I 
These different physiologic mechanisms for a- versus mixed a- and f3-adrenergic 
agents also occur in treatment of hypotension during spinal anaesthesia. Thus, initial 
treatment can be tailored to a only for patients with hypotension and mixed a and f3 
for patients with both hypotension and bradycardia. In patients with cardiac disease 
abrupt increase of the blood pressure and heart rate (leading to increased oxygen 
demand) can result in myocardial ischemia and lead to myocardial dysfunction or 
overt tissue infarction (Barash et a/., 2001 ). 
2.3.2 Thermoregulation 
Hypothermia is associated with an increased incidence of myocardial ischemia, cardiac 
morbidity, wound infection, blood loss, and transfusion requirements (Sessler, 2000). 
Both general and regional anaesthesia impairs temperature homeostasis to a similar 
degree (Szmuk eta/., 1997, Cattaneo eta/., 2000). 
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There are three main mechanisms causing core hypothermia (Sessler, 2000, Szmuk et 
a/., 1997, Leslie and Sessler, 1996, Frank et a/., 1999). The first is redistribution of 
central heat to the periphery caused by vasodilatation from sympathetic block. This 
effect is maximal during the first 30-60 min, causes a decrease in core temperature of 
approximately 1-2°C, and depends on extent of sensory block and patient age. The 
second mechanism is loss of thermoregulation characterized by reduced shivering and 
vasoconstriction thresholds during spinal anaesthesia. This abnormal tolerance for 
hypothermia occurs because of subjective warmth exceeding the actual surface 
temperature increase from sympathectomy. This exaggerated sense of warmth is 
proportional to extent of sensory and sympathetic block (Szmuk et a/., 1997) and 
decreases thresholds for shivering and vasoconstriction. Thus, hypothermia may occur 
during spinal anaesthesia without a conscious perception of cold (Ben-David et a/., 
1997). Finally, with loss of thermoregulatory vasoconstriction below the level of the 
sympathetic block., there is increased heat loss from vasodilatation. Spinal anaesthesia 
will predictably cause core hypothermia within 30-60 min, and patients should be 
monitored and actively warmed (Sessler, 2000). Spinal anaesthesia accelerates 
rewarming compared with general anaesthesia because of the residual sympathetic 
block and vasodilatation (Szmuk eta/., 1997). 
2.3.3 Supraspinal Effects on Consciousness 
Central neuraxial anaesthesia may have direct effects on suppression of consciousness, 
and multiple studies have observed that patients appear drowsy after spinal anaesthesia 
despite lack of sedative medications (Pollock et a/., 2000, Hodgson and Liu, 2000). 
Correspondingly, both spinal and epidural anaesthesia reduce the hypnotic 
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requirements of midazolam, isoflurane, sevoflurane, and thiopental in surgical patients 
and laboratory studies (Hodgson et al., 1999). Possible mechanisms for decreased 
consciousness during spinal anaesthesia include rostral spread of local anaesthetics or 
decrease in reticular activating system activity caused by interruption of afferent input 
(Pollock et al., 2000). Degree of sedation caused by spinal anaesthesia is related to 
peak block height, with greater sedation observed with greater block heights (Gentili et 
al., 1998). This finding indirectly supports the hypothesis that greater loss of afferent 
input from extension of spinal anaesthesia increasingly suppresses consciousness. Time 
of maximal sedation with spinal anaesthesia shows a biphasic distribution, with one 
peak occurring during peak spinal block ( ~30 min after injection) and a second peak 
occurring later, approximately 1 h after injection (Pollock et al., 2000). Mechanisms 
for the second peak in sedation are unclear and may include late rostral spread of local 
anaesthetic into the brain or psychological relief over regression of spinal anaesthesia. 
Clinical relevance for these observations is the decreased need for pharmacologic 
sedatives with the use of spinal anaesthesia. 
2.4 PHYSIOLOGIC CHANGES DURING PREGNANCY 
2.4.1 Hematologic Alterations 
Increased mineralocorticoid activity produces sodium retention and increased body 
water content (Lund and Donovan, 1967). Plasma volume and total blood volume 
begin to increase in early gestation, resulting in a final increase of 40-50% and 25-
40% respectively, at term. The relatively smaller increase in red blood cell volume 
(20%) accounts for a reduction in hemoglobin (to 11-12 g·dr1) and hematocrit (to 
35%) (Lund and Donovan, 1967). 
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The leukocyte count ranges from 8000-IO,OOO per mm3 throughout pregnancy, 
platelet count remains unchanged. Plasma fibrinogen concentrations increase during 
normal pregnancy by 50%, whereas clotting factor activity is variable (Pritchard and 
Macdonald, I 980). Serum cholinesterase activity declines to a level of 20% below 
normal by term, and reaches a nadir in the puerperium. Total plasma protein 
concentration declines to less than 6 g·dr1 at term, whereas the total amount in the 
circulation increases (Coryell et a/., I 950). The albumin-globulin ratio declines 
because of the relatively greater reduction in albumin concentration. A decrease in 
serum protein concentration may be clinically significant, in that the free fractions of 
protein-bound drugs can be expected to increase. 
2.4.2 Cardiovascular Changes 
Oxygen consumption increases during pregnancy, the maternal cardiovascular system 
adapts to meet the metabolic demands of a growing fetus. Decreased vascular 
resistance due to estrogens, progesterone, and prostacyclin may be the initiating factor 
(Goodman et a/., 1982). Lowered resistance is found in the uterine, renal, and other 
vascular beds~ at term, there is an increase in heart rate (I 5-25% ), and cardiac output 
(up to 50%) above that of the nonpregnant state. Arterial blood pressure decreases 
slightly because the decrease in peripheral resistance exceeds the increase in cardiac 
output. Additional increases in cardiac output occur during labor (when cardiac output 
may reach 12- 14·min-1) and also in the immediate postpartum period owing to added 
blood volume from the contracted uterus. From the second trimester, aortocaval 
compression by the enlarged uterus becomes progressively more important, reaching 
its maximum at 36-38 weeks, after which it may decrease as the fetal head descends 
into the pelvis (Kerr eta/., I 964). 
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Studies of cardiac output, measured with the patient in the supine position during the 
last weeks of pregnancy, have indicated a decrease to nonpregnant levels; however, 
this decrease was not observed when patients were in the lateral decubitus position 
(Kerr et a/., 1964). Supine hypotensive syndrome, which occurs in 10% of pregnant 
women because of venous occlusion, results in maternal tachycardia, arterial 
hypotension, faintness, and pallor (Howard BK eta/., 1953). Compression of the lower 
aorta in this position may further decrease uteroplacental perfusion and result in fetal 
asphyxia. Therefore, uterine displacement or lateral pelvic tilt should be applied 
routinely during the second and third trimesters of pregnancy. Changes in the 
electrocardiogram may also occur. Left axis deviation results from the upward 
displacement of the heart by the gravid uterus, and there is also a tendency toward 
premature atrial contractions, sinus tachycardia, and paroxysmal supraventricular 
tachycardia. 
2.4.3 Ventilatory Changes 
Increased extracellular fluid and vascular engorgement may not only lead to edema of 
the extremities but may compromise the upper airway. Many pregnant women 
complain of difficulty with nasal breathing, and the friable nature of the mucous 
membranes during pregnancy can cause severe bleeding, especially on insertion of 
nasopharyngeal airways or nasogastric and endotracheal tubes. Airway oedema may 
be particularly severe in women with pre-eclampsia, in patients placed in the 
trendelenburg position for prolonged periods, or with concurrent use of tocolytic 
agents. It may also be difficult to perform laryngoscopy in obese, short-necked 
parturient with enlarged breasts. Use of a short-handled laryngoscope has proved 
helpful. 
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The level of the diaphragm rises as the uterus increases in size and accompanied by an 
increase in the anteroposterior and transverse diameters of the thoracic cage. From the 
fifth month, the expiratory reserve volume, residual volume, and functional residual 
capacity (FRC) decrease the latter to 20% less than in the nonpregnant state (Prowse 
and Gaensler, 1965). 
Concomitantly, there is an increase in inspiratory reserve volume, so that total lung 
capacity remains unchanged. In most pregnant women, a decreased FRC does not 
cause problems, but those with pre-existing alterations in closing volume as a result of 
smoking, obesity, or scoliosis may experience early airway closure with advancing 
pregnancy, leading to hypoxemia. 
The trendelenburg and supine positions also exacerbate the abnormal relationship 
between closing volume and FRC. The residual volume and functional residual 
capacity return to normal shortly after delivery. Progesterone-induced relaxation of 
bronchiolar smooth muscle decreases airway resistance, whereas lung compliance 
remains unchanged. 
Minute ventilation increases from the beginning of pregnancy to a maximum of 50% 
above normal at term (Prowse and Gaensler, 1965). This is accomplished by a 40% 
increase in tidal volume and a 15% increase in respiratory rate. 
Dead space does not change significantly, and thus alveolar ventilation is increased by 
70% at term. 
After delivery, as blood progesterone levels decline, ventilation returns to normal 
within 1-3 weeks (Moya and Smith, 1965). 
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2.4.4 Metabolnsm 
Basal oxygen consumption increases during early pregnancy, with an overall increase 
of 20% by term (Prowse and Gaensler, 1965). However, increased alveolar ventilation 
leads to a reduction in the partial pressure of carbon dioxide in arterial blood (PaC02) 
to 32 mm Hg and an increase in the partial pressure of oxygen in arterial blood (Pa02) 
to 106 mm Hg. The plasma buffer base decreases from 4 7 to 42 mEq·r1 ~ and therefore 
the pH remains practically unchanged. The maternal uptake and elimination of 
inhalational anesthetics is enhanced because of the increased alveolar ventilation and 
decreased FRC (Moya and Smith, 1965). However, the decreased FRC and increased 
metabolic rate predispose the mother to development of hypoxemia during periods of 
apnea/hypoventilation, such as may occur during airway obstruction or prolonged 
attempts at tracheal intubation (Archer and Marx, 1974). Human placental lactogen 
and cortisol increase the tendency toward hyperglycemia and ketosis, which may 
exacerbate pre-existing diabetes mellitus. The patient's ability to handle a glucose load 
is decreased, and the transplacental passage of glucose may stimulate fetal secretion 
of insulin, leading in turn to neonatal hypoglycemia in the immediate postpartum 
period (Datta eta/., 1982). 
2.4.5 Gastrointestinal Changes 
Enhanced progesterone production causes decreased gastrointestinal motility and 
slower absorption of food. Gastric secretions are more acidic and lower esophageal 
sphincter (LES) tone is decreased. A delay in gastric emptying can already be 
demonstrated by the end of the first trimester (Simpson et al., 1988). 
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Uterine growth leads to upward displacement and rotation of the stomach, with 
increased pressure and a further delay in gastric emptying. By the 34th week~ 
evacuation of a watery meal may be prolonged by 60% (Davison et a/., 1970). Pain, 
anxiety, and administration of opioids (systemic or neuraxial) and belladonna 
alkaloids may further exacerbate this delay. 
The risk of regurgitation on induction of general anaesthesia depends, in part, on the 
gradient between the LES and intragastric pressures. In most patients, the gradient 
increases after succinylcholine administration because the increase in LES pressure 
exceeds the increase in intragastric pressure. However, in parturients with 
"heartburn," the LES tone is greatly reduced (Brock-Utne eta/., 1981). 
The efficacy of prophylactic nonparticulate antacids is diminished by inadequate 
mixing with gastric contents, improper timing of administration, and the tendency for 
antacids to increase gastric volume. Administration of histamine (H2) receptor 
antagonists, such as cimetidine and ranitidine, requires careful timing. A good case 
can be made for the administration of intravenous (IV) metoclopramide before 
elective cesarean section. This dopamine antagonist hastens gastric emptying and 
increases resting LES tone in both nonpregnant and pregnant women (Wyner and 
Cohen, 1982). However, conflicting reports have appeared on its efficacy and on the 
frequency of side effects such as extrapyramidal reactions and transient neurological 
dysfunction (Cohen et al., 1984, Scheller and Sears, 1987). Although no routine 
prophylactic regimen can be recommended with certainty, it is the authors' preference 
to administer at least a nonparticulate antacid before caesarean section and to use 
regional anaesthesia whenever possible. 
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A rapid-sequence induction of anaesthesia, application of cricoids pressure, and 
intubation with a cuffed endotracheal tube are required for all pregnant women 
receiving general anaesthesia from the 12th week of gestation (Simpson eta/., 1988). 
These recommendations also pertain to women in the immediate postpartum period 
because there is uncertainty as to when gastric volume returns to normal. 
2.4.6 Altered Drug Responses 
The minimum alveolar concentration (MAC) for inhalational agents is decreased by 
8-12 weeks of gestation and may be related to an increase in progesterone levels (Gin 
and Chan, 1994). In addition, lower doses of local anaesthetic are needed per 
dermatomal segment of epidural or spinal block. 
This has been attributed to an increased spread of local anaesthetic in the epidural and 
subarachnoid spaces, which occurs as a result of epidural venous engorgement. 
An increased neural sensitivity to local anaesthetics also has been suggested, which 
may be mediated by progesterone (Datta eta/., 1983). 
2.4. 7 Placental Transfer 
Placental transfer of drugs depend on the physicochemical characteristics of the drug 
itself, maternal drug concentrations in the plasma, properties of the placenta, and 
hemodynamic events within the fetomatemal unit. 
Drugs cross biologic membranes by simple diffusion, the rate of which is determined 
by the Fick principle, 
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which states that: 
Q/t = KA( Cm - Cr)/D 
where Q/t = rate of diffusion, 
K = diffusion constant, 
A = surface area available for exchange, 
Cm =concentration of free drug in maternal blood, 
Cr = concentration of free drug in fetal blood, and 
D =thickness of diffusion barrier. 
The diffusion constant (K) of the drug depends on physicochemical characteristics 
such as molecular size, lipid solubility, and degree of ionization. Compounds with a 
molecular weight of less than 500 Daltons are unimpeded in crossing the placenta, 
whereas those with molecular weights of 500-1000 Daltons are more restricted. 
Most drugs commonly used by the anaesthesiologist have molecular weights that 
permit easy transfer. If blood flow to the fetal side of the placenta can be measured, as 
in some animal models, calculating the placental clearance may be a more appropriate 
way of expressing drug transfer to the fetus (Reynold F and Knott C, 1989). Drugs 
that are highly lipid soluble cross biologic membranes more readily, and the degree of 
ionization is important because the nonionized moiety of a drug is more lipophilic 
than the ionized one. 
Local anaesthetics and opioids are weak bases, with a relatively low degree of 
ionization and considerable lipid solubility. In contrast, muscle relaxants are less 
lipophilic and more ionized, and their rate of placental transfer is therefore more 
limited. 
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The relative concentrations of drug existing in the nonionized and ionized forms can 
be predicted from the Henderson-Hasselbalch equation: 
pH= pKa + log(base)/(cation) 
The ratio of base to cation becomes particularly important with local anaesthetics 
because the nonionized form penetrates tissue barriers, whereas the ionized form is 
pharmacologically active in blocking nerve conduction. The pKa is the pH at which 
the concentrations of free base and cation are equal. For the amide local anaesthetics, 
the pKa values (7. 7-8.1) are sufficiently close to physiologic pH that changes in 
maternal or fetal biochemical status may significantly alter the proportion of ionized 
and nonionized drug present. At equilibrium, the concentrations of nonionized drug in 
the fetal and maternal plasma are equal. In the case of the acidotic fetus, a greater 
tendency for drug to exist in the ionized form, which cannot diffuse back across the 
placenta into the maternal plasma, causes a larger total amount of drug to accumulate 
in the fetal plasma and tissues. This is the mechanism for the phenomenon termed ion 
trapping (Brown eta/., 1976). 
The effects of maternal plasma protein binding on the rate and amount of drug 
transferred to the fetus are not so well understood. Animal studies have shown that the 
transfer rate is slower for drugs that are extensively bound to maternal plasma 
proteins (Hamshaw et a/., 1984). In sheep, the low fetomatemal ratio of bupivacaine 
plasma concentrations has been attributed to the difference between fetal and maternal 
plasma protein binding, rather than to extensive fetal tissue uptake (Kennedy et 
al., 1986). 
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